Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

PI-88 one step closer to clinical testing

Feb. 24, 1998

DBD meets with FDA to discuss dibromodulcitol progress

Feb. 24, 1998

Sponge-derived natural product shows promise as a new cancer therapeutic

Feb. 24, 1998

Recombinant methioninase shows clinical efficacy in depleting serum methionine

Feb. 24, 1998

Encouraging results obtained with Hycamtin in multiple myeloma

Feb. 23, 1998

In vitro study shows COX-1/COX-2 inhibition not associated with anticancer activity

Feb. 23, 1998

Pharmacia & Upjohn develops new antiproliferative agents

Feb. 23, 1998

PKC inhibitors under study at Hoechst Marion Roussel

Feb. 20, 1998

New natural or semisynthetic cytotoxic alkaloids from Indena

Feb. 19, 1998

Merck obtains rights to novel drug screening technology

Feb. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...